FDA Press Releases - EIN Presswire - Press Release Distribution Service

Published on August 26, 2021 - 14:40 GMT

FDA Releases PFAS Testing Results from First Survey of Nationally Distributed Processed Foods

FDA News Release Nearly all foods tested had no detectable levels of PFAS; no evidence that levels found in samples indicate need to avoid particular foods For Immediate Release: August 26, 2021 Today, the U.S. Food and Drug Administration released the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 24, 2021 - 19:56 GMT

Coronavirus (COVID-19) Update: August 24, 2021

For Immediate Release: August 24, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: On Aug. 22, the FDA updated the Pfizer-BioNTech emergency use authorization ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 23, 2021 - 16:26 GMT

FDA and Mexican Counterparts Report Progress and Next Steps for Food Safety Partnership

FDA News Release The following is attributed to Frank Yiannas, FDA Deputy Commissioner for Food Policy and Response. For Immediate Release: August 23, 2021 As part of our ongoing efforts to ensure the safety of food imported from Mexico and advance …

Distribution channels:

Published on August 23, 2021 - 13:56 GMT

FDA Approves First COVID-19 Vaccine

For Immediate Release: August 23, 2021 Today, the U.S. Food and Drug Administration approved the first COVID-19 vaccine. The vaccine has been known as the Pfizer-BioNTech COVID-19 Vaccine, and will now be marketed as Comirnaty (koe-mir’-na-tee), for the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 20, 2021 - 18:00 GMT

Coronavirus (COVID-19) Update: August 20, 2021

For Immediate Release: August 20, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, on August 19, the agency …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 18, 2021 - 17:50 GMT

Joint Statement from HHS Public Health and Medical Experts on COVID-19 Booster Shots

For Immediate Release: August 18, 2021 Today, public health and medical experts from the U.S. Department of Health and Human Services (HHS) released the following statement on the Administration’s plan for COVID-19 booster shots for the American people. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 17, 2021 - 19:21 GMT

FDA In Brief: FDA Issues a Corporate-Wide Warning Letter to Company Associated with Contaminated Pet Food, Hundreds of Adverse ...

For Immediate Release: August 17, 2021 The following quote is attributed to Steven M. Solomon, M.P.H., D.V.M., director of the FDA’s Center for Veterinary Medicine “The FDA is dedicated to taking all steps possible to help pet owners have confidence that …

Distribution channels:

Published on August 13, 2021 - 20:46 GMT

Coronavirus (COVID-19) Update: August 13, 2021

For Immediate Release: August 13, 2021 The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: As part of the FDA’s effort to protect consumers, on August 10, the agency issued a warning letter …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 13, 2021 - 04:01 GMT

Coronavirus (COVID-19) Update: FDA Authorizes Additional Vaccine Dose for Certain Immunocompromised Individuals

FDA News Release Other fully vaccinated individuals do not need an additional vaccine dose right now For Immediate Release: August 12, 2021 Español Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 12, 2021 - 20:37 GMT

FDA Grants First of its Kind Indication for Chronic Sleep Disorder Treatment

For Immediate Release: August 12, 2021 The U.S. Food and Drug Administration today approved a new indication for Xywav for idiopathic hypersomnia (IH) in adults. IH is an uncommon chronic sleep disorder that causes people to be excessively sleepy during …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 12, 2021 - 15:11 GMT

Coronavirus (COVID-19) Update: FDA Authorizes New Long-Acting Monoclonal Antibodies for Pre-exposure Prevention of COVID-19 in ...

For Immediate Release: December 08, 2021 Today, the U.S. Food and Drug Administration issued an emergency use authorization (EUA) for AstraZeneca’s Evusheld (tixagevimab co-packaged with cilgavimab and administered together) for the pre-exposure …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 10, 2021 - 18:14 GMT

FDA Approves Innovative Treatment for Pediatric Patients with Congenital Athymia

For Immediate Release: October 08, 2021 Today, the U.S. Food and Drug Administration approved Rethymic for the treatment of pediatric patients with congenital athymia, a rare immune disorder. Rethymic is the first thymus tissue product approved in the U.S. …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 10, 2021 - 14:33 GMT

Coronavirus (COVID-19) Update: October 8, 2021

For Immediate Release: October 08, 2021 The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: On Tuesday October 5, the FDA issued a safety communication to alert test users, caregivers, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 10, 2021 - 14:10 GMT

FDA In Brief: FDA Warns Public and Health Care Professionals Not to Use Needle-free Devices for Injection of Dermal Fillers

For Immediate Release: October 08, 2021 The following quote is attributed to Binita Ashar, M.D., director of the Office of Surgical and Infection Control Devices in FDA’s Center for Devices and Radiological Health: “Today, the FDA is warning the public and …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on August 9, 2021 - 11:25 GMT

FDA In Brief: FDA Announces Public Workshop to Reconsider Mandatory Prescriber Education for Opioids

For Immediate Release: September 08, 2021 The following quote is attributed to Patrizia Cavazzoni, M.D., director of the FDA’s Center for Drug Evaluation and Research “The opioid crisis continues to evolve and there are still relevant concerns with …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 30, 2021 - 21:48 GMT

Coronavirus (COVID-19) Update: July 30, 2021

For Immediate Release: July 30, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, the FDA revised the Emergency Use Authorization (EUA) for REGEN-COV ( …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 28, 2021 - 21:32 GMT

FDA Approves First Interchangeable Biosimilar Insulin Product for Treatment of Diabetes

For Immediate Release: July 28, 2021 Today, the U.S. Food and Drug Administration approved the first interchangeable biosimilar insulin product, indicated to improve glycemic control in adults and pediatric patients with Type 1 diabetes mellitus and in …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 28, 2021 - 17:33 GMT

FDA In Brief: FDA Warns Firm with Over 15 Million Products Listed with FDA to Remove Unauthorized E-Cigarette Products from Market

For Immediate Release: July 28, 2021 The following quote is attributed to Mitch Zeller, J.D., director of FDA’s Center for Tobacco Products “Today, the FDA issued a warning letter to a company with over 15 million tobacco products listed with the FDA, …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 23, 2021 - 20:23 GMT

Coronavirus (COVID-19) Update: July 23, 2021

For Immediate Release: July 23, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The agency updated its FDA COVID-19 Response At-A-Glance Summary, which provides …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on July 20, 2021 - 21:21 GMT

Coronavirus (COVID-19) Update: July 20, 2021

For Immediate Release: July 20, 2021 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: Today, Acting FDA Commissioner Janet Woodcock, M.D. testified before the U.S. …

Distribution channels: Healthcare & Pharmaceuticals Industry